Abstract：Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent among more than 200 countries around the world. It has a long incubation period, strong infectivity, and various modes of transmission. People are generally susceptible to it. At present, there are no specific drugs and vaccines that can treat or prevent the coronavirus disease 2019 (COVID-19) caused by the virus. However, notable progress has been achieved in theoretical researches and clinical analysis of SARS-CoV-2 and COVID-19. This arti-cle summarized the viral genome and origin analysis, the relationship between the receptor angiotensin con-verting enzyme 2 (ACE2) and the viral infection and pathogenesis, as well as current COVID-19 therapeutic drugs, in hope of providing a reference for awareness of future epidemic risks and searching for potential an-tiviral drugs.
引用本文:
王康泓. SARS-CoV-2感染机制分析与COVID-19治疗药物研究进展[J]. 生命科学研究, 2020, 24(6): 442-451.
WANG Kang-hong. Research Progress of SARS-CoV-2 Infection Mechanisms and COVID-19 Therapeutic Medicines. Life Science Research, 2020, 24(6): 442-451.
